ArticleUrologic oncology2022

Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.

Agreen Hadadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.